Biotech · Private company
Afimmune
Track this companyFree. Adds Afimmune to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- 1000mg DS102 (BID)Phase 2 · Severe Acute Decompensated Alcoholic HepatitisClinicalTrials.gov · fetched Nov 12, 2026
- DS102Phase 2 · HypertriglyceridemiaClinicalTrials.gov · fetched Nov 12, 2026
- EpeleutonPhase 2 · Sickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell DiseasePHASE2 · COMPLETED · started Jan 10, 2024ClinicalTrials.gov NCT05861453 · fetched Nov 12, 2026
- Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 DiabetesPHASE2 · TERMINATED · started Oct 13, 2020ClinicalTrials.gov NCT04365400 · fetched Nov 12, 2026
- Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic HepatitisPHASE2 · TERMINATED · started Nov 28, 2018ClinicalTrials.gov NCT03452540 · fetched Nov 12, 2026